33620 Results

People

  1. Ladanyi
    Ladanyi
  2. Giralt
    Giralt
  3. Motzer
    Motzer
  4. Reuter
    Reuter
  5. Perales
    Perales
  6. Scher
    Scher
  7. Zelenetz
    Zelenetz
  8. Berger
    Berger
  9. Al-Ahmadie
    Al-Ahmadie
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)
  7. Department of Pathology and Laboratory Medicine (5172)
  8. Surgery (4871)
  9. Sloan Kettering Institute Faculty (3826)
  10. Sloan Kettering Institute Postdocs (3612)
  1. "Meeting abstract"
Formats
  1. Meeting Abstract (33620)
Groups
  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)

More Groups

People
  1. Marc Ladanyi (641)
  2. Sergio Giralt (632)
  3. Robert Motzer (574)
  4. Victor Reuter (568)
  5. Miguel-Angel Perales (482)
  6. Howard Scher (463)

More People

Years
  1. 2025 (295)
  2. 2024 (1694)
  3. 2023 (1954)
  4. 2022 (2196)
  5. 2021 (1731)
  6. 2020 (1901)

More Years

Publications
  1. Journal of Clinical Oncology (6252)
  2. Blood (3939)
  3. Laboratory Investigation (1846)
  4. Cancer Research (1822)
  5. International Journal of Radiation Oncology, Biology, Physics (1643)
  6. Modern Pathology (1494)

More Publications

Publishers
  1. American Society of Clinical Oncology (6251)
  2. Elsevier Inc. (4694)
  3. American Society of Hematology (3939)
  4. American Association for Cancer Research (3045)
  5. Nature Publishing Group (2151)
  6. Oxford University Press (2096)

More Publishers

Results (33620)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Targeting NFE2L2 mutations in advanced squamous cell lung cancers with the TORC1/2 inhibitor TAK228
    Meeting Abstract

    Paik, P. K.; Qeriqi, B.; Ahn, L. S. H.; Ginsberg, M. S.; Tandon, N.; McFarland, D.; Doyle, L. A.; de Stanchina, E.; Rudin, C. M.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Exploratory analysis of percentage of genomic loss of heterozygosity (LOH) in patients with platinum-sensitive recurrent ovarian carcinoma (rOC) in ARIEL3
    Meeting Abstract

    Oaknin, A.; Ledermann, J. A.; Oza, A. M.; Lorusso, D.; Aghajanian, C.; Dean, A. P.; Colombo, N.; Weberpals, J. I.; Clamp, A. R.; Scambia, G.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Risk-adapted therapy for pediatric Hodgkin lymphoma (HL) results in lower risk of late effects: A report from the Childhood Cancer Survivor Study (CCSS)
    Meeting Abstract

    Oeffinger, K. C.; Stratton, K.; Hudson, M. M.; Leisenring, W.; Howell, R. M.; Wolden, S. L.; Constine, L. S.; Diller, L.; Henderson, T. O.; Sklar, C. A.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Tumor mutation burden and efficacy of targeted therapy in patients with EGFR mutant lung cancers
    Meeting Abstract

    Offin, M. D.; Rizvi, H.; Tenet, M.; Ni, A.; Sanchez Vega, F.; Kris, M. G.; Rudin, C. M.; Riely, G. J.; Yu, H. A.; Hellmann, M. D.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Circulating tumor DNA in advanced lung cancers: A prospective evaluation of matched therapy and shedding detection
    Meeting Abstract

    Offin, M. D.; Stephens, D.; Sabari, J. K.; Makhnin, A.; Myers, M.; Ni, A.; Pavlakis, N.; Clarke, S. J.; Tandon, N.; Datta, S.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • MORPHEUS: A phase Ib/II trial platform evaluating the safety and efficacy of multiple cancer immunotherapy (CIT) combinations in patients (pts) with gastric or pancreatic cancer
    Meeting Abstract

    Oh, D. Y.; Al-Batran, S. E.; Chung, H. C.; Hollebecque, A.; Iqbal, S.; Kim, K. P.; Lacy, J.; Manji, G. A.; O'Reilly, E. M.; Rahma, O. E.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Outcomes of lung cancer patients with leptomeningeal metastases in the targeted therapy era
    Meeting Abstract

    Nevel, K. S.; DiStefano, N.; Lin, X.; Cowan, A.; Skakodub, A.; Ogilvie, S.; Pentsova, E.; Boire, A. A.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Two-year efficacy and safety update from JAVELIN Merkel 200 part A: A registrational study of avelumab in metastatic Merkel cell carcinoma progressed on chemotherapy
    Meeting Abstract

    Nghiem, P.; Bhatia, S.; Brohl, A. S.; Hamid, O.; Mehnert, J. M.; Terheyden, P.; Shih, K. C.; Brownell, I.; Lebbé, C.; Lewis, K. D.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • HuMab-5B1 (MVT-5873), a mAb targeting sLe(a), in combination with first-line gemcitabine plus nab-paclitaxel (gem/nab-P) for patients with pancreatic cancer (PDAC) and other CA19-9 positive malignancies
    Meeting Abstract

    O'Reilly, E. M.; Borazanci, E. H.; Yu, K. H.; Varghese, A. M.; Estrella, H.; Kamins, D.; Melink, T.; Dorr, K.; Maffuid, P.; Gutheil, J.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Contessa: A multinational, multicenter, randomized, phase 3 registration study of tesetaxel in patients (Pts) with HER2-, hormone receptor + (HR+) locally advanced or metastatic breast cancer (MBC)
    Meeting Abstract

    O'Shaughnessy, J.; Piccart-Gebhart, M. J.; Schwartzberg, L. S.; Cortes, J.; Harbeck, N.; Im, S. A.; Rugo, H. S.; Untch, M.; Yardley, D. A.; Bondarenko, I.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save